Laidlaw Downgrades Mast Therapeutics (MSTX) to Neutral

September 21, 2016 11:46 AM EDT
Get Alerts MSTX Hot Sheet
Price: $0.08 -11.11%

Rating Summary:
    4 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 29 | New: 38
Trade MSTX Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Laidlaw downgraded Mast Therapeutics (NYSE: MSTX) from Buy to Neutral.

For an analyst ratings summary and ratings history on Mast Therapeutics click here. For more ratings news on Mast Therapeutics click here.

Shares of Mast Therapeutics closed at $0.59 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment